Does therapeutic angiogenesis overcome CKD?
Taniyama
Yoshiaki
Y
Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. taniyama@cgt.med.osaka-u.ac.jp
Morishita
Ryuichi
R
D000818:Animals; D015316:Genetic Therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D051379:Mice; D018919:Neovascularization, Physiologic; D013234:Stem Cells / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology
C104146:SALL1 protein, human; D014157:Transcription Factors